Furthermore, we studied the immune cell profiles in tumor tissue and tumor-draining lymph nodes (TDLNs) after various treatments to elucidate the impact of the combination therapy of Fn-OMV and oHSV on antitumor immunity. Here, FN1 is linked to neoplasm.